Literature DB >> 2467835

Induction of angiogenesis by intraperitoneal injection of asbestos fibers.

R M Branchaud1, J L MacDonald, A B Kane.   

Abstract

Tumors and activated macrophages release angiogenic factors that stimulate migration and proliferation of capillaries. We studied the development of angiogenesis before the appearance of mesotheliomas in C57B1/6 mice. Weekly i.p. injections of crocidolite asbestos fibers produced mesotheliomas after 30-50 wk. The initial histologic response to asbestos fibers was a nodular lesion on the peritoneal lining composed of clusters of fibers, activated macrophages, and proliferating mesenchymal cells. The earliest visible evidence of angiogenesis was seen surrounding 7% of these lesions 14 days after a single injection of 200 micrograms of crocidolite asbestos fibers. After six weekly injections, 30% of the lesions containing asbestos fibers were surrounded by a capillary network radiating toward the center of the lesion. Other mineral fibers, including chrysotile asbestos and fiberglass, also induced angiogenesis after six weekly injections. In contrast, only 8% of the lesions containing short asbestos fibers (90.6% less than or equal to 2.0 microns) and 9% of the lesions containing silica particles showed evidence of angiogenesis. We conclude that tumorigenic mineral fibers induce angiogenesis in the peritoneal lining, whereas nontumorigenic mineral particles or short asbestos fibers are less effective. Ingrowth of new blood vessels around clusters of asbestos fibers may facilitate the later emergence of mesotheliomas at these sites.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2467835     DOI: 10.1096/fasebj.3.6.2467835

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  7 in total

1.  Cell permeability, migration, and reactive oxygen species induced by multiwalled carbon nanotubes in human microvascular endothelial cells.

Authors:  M Pacurari; Y Qian; W Fu; D Schwegler-Berry; M Ding; V Castranova; N L Guo
Journal:  J Toxicol Environ Health A       Date:  2012

Review 2.  Nonpulmonary outcomes of asbestos exposure.

Authors:  Melisa Bunderson-Schelvan; Jean C Pfau; Robert Crouch; Andrij Holian
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

3.  Investigational approaches for mesothelioma.

Authors:  Veerle F Surmont; Eric R E van Thiel; Karim Vermaelen; Jan P van Meerbeeck
Journal:  Front Oncol       Date:  2011-08-22       Impact factor: 6.244

4.  Increased focal adhesion kinase- and urokinase-type plasminogen activator receptor-associated cell signaling in endothelial cells exposed to asbestos.

Authors:  A Barchowsky; B M Lannon; L C Elmore; M D Treadwell
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

Review 5.  Reactive oxygen species a double-edged sword for mesothelioma.

Authors:  Serena Benedetti; Barbara Nuvoli; Simona Catalani; Rossella Galati
Journal:  Oncotarget       Date:  2015-07-10

Review 6.  Switching off malignant mesothelioma: exploiting the hypoxic microenvironment.

Authors:  Noushin Nabavi; Kevin L Bennewith; Andrew Churg; Yuzhuo Wang; Colin C Collins; Luciano Mutti
Journal:  Genes Cancer       Date:  2016-11

Review 7.  Spotlight on bevacizumab and its potential in the treatment of malignant pleural mesothelioma: the evidence to date.

Authors:  Pavel A Levin; Jonathan E Dowell
Journal:  Onco Targets Ther       Date:  2017-04-07       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.